Komplette und langfristige Regredienz einer leichten depressiven Störung unter Interferon-β-1b-Behandlung nach achtwöchiger Therapiepause

Translated title of the contribution: Complete and long-lasting resolution of mild depressive symptoms after therapy interruption for eight weeks during interferon β-1b Treatment

A. Baumgartner, S. Rauer*

*Corresponding author for this work

Abstract

Here, we describe a female patient with relapsing-remitting multiple sclerosis, who developed severe side effects while being treated with glatiramer acetate (Copaxone). Thus, therapy with Copaxone was stopped and the patient received interferon -1b. Under this therapy an episode of mild depression with a lack of drive and aggressiveness occurred. These symptoms, considered as possible adverse effects, completely resolved during treatment interruption. Afterwards, therapy with interferon -1b was restarted and well tolerated without any adverse effects. This case demonstrates that mild depressive symptoms under treatment with interferon -1b are not necessarily a reason for a change of treatment.

Translated title of the contributionComplete and long-lasting resolution of mild depressive symptoms after therapy interruption for eight weeks during interferon β-1b Treatment
Original languageGerman
JournalAktuelle Neurologie, Supplement
Volume39
Issue numberSUPPL. 1
Pages (from-to)S34-S36
ISSN1437-2754
DOIs
Publication statusPublished - 2012

Research Areas and Centers

  • Health Sciences

DFG Research Classification Scheme

  • 206-08 Cognitive and Systemic Human Neuroscience
  • 206-09 Biological Psychiatry

Cite this